Microbix Biosystms (TSE:MBX) has released an update.
Microbix Biosystems Inc., a life sciences company specializing in biological products for human health, is set to present at the Bloom Burton & Co. Healthcare Investor Conference in Toronto. The event, scheduled for April 16 and 17, 2024, will see Microbix’s CEO deliver a presentation aimed at connecting with investors from Canada, the U.S., and internationally. Microbix, known for its diagnostic assay ingredients and quality assessment products, seeks to further its reach in the healthcare and life sciences sectors.
For further insights into TSE:MBX stock, check out TipRanks’ Stock Analysis page.
